Review
Copyright ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Obstet Gynecol. Feb 10, 2016; 5(1): 28-38
Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.28
MicroRNAs: New players in endometriosis
Josep Marí-Alexandre, Moisés Barceló-Molina, María Olcina-Guillem, Javier García-Oms, Aitana Braza-Boïls, Juan Gilabert-Estellés
Josep Marí-Alexandre, Moisés Barceló-Molina, María Olcina-Guillem, Aitana Braza-Boïls, Grupo de Hemostasia, Trombosis, Aterosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain
Javier García-Oms, Juan Gilabert-Estellés, Área Maternoinfantil, Hospital General Universitario, 46014 Valencia, Spain
Juan Gilabert-Estellés, University of Valencia, 46010 Valencia, Spain
Author contributions: Marí-Alexandre J, Barceló-Molina M, Olcina-Guillem M and García-Oms J have performed the literature review and helped in the elaboration of the manuscript; Marí-Alexandre J, Braza-Boïls A and Gilabert-Estellés J have written and supervised the final version of the manuscript.
Supported by ISCIII and FEDER, Nos. PI011/00091, PI011/00566, PI14/01309, PI14/00253 and FI12/00012; RIC, Nos. RD12/0042/0029 and RD12/0042/0050; IIS La Fe 2011-211; Prometeo, No. 2011/027; and Sara Borrell Contract, No. CD13/0005.
Conflict-of-interest statement: Authors have no conflict of interest for this paper.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Juan Gilabert-Estellés, MD, PhD, Professor of Medicine, Chief of the Área Maternoinfantil, Hospital General Universitario, Av. Tres Cruces 2, 46014 Valencia, Spain. gilabert_juaest@gva.es
Telephone: +34-63-8064295 Fax: +34-96-1972014
Received: July 29, 2015
Peer-review started: August 6, 2015
First decision: September 16, 2015
Revised: December 2, 2015
Accepted: January 5, 2016
Article in press: January 7, 2016
Published online: February 10, 2016
Abstract

Endometriosis is an estrogen-dependent inflammatory disorder that limits the quality of life of affected women. This pathology affects 10% of reproductive-age women, although the prevalence in those patients experiencing pain, infertility or both is as high as 35%-50%. Endometriosis is characterized by endometrial-like tissue outside the uterus, primarily on the pelvic peritoneum, ovaries and the pouch of Douglas. Despite extensive research endeavours, a unifying theory regarding the exact etiopathogenic mechanism of this high prevalent and incapacitating condition is still lacking, although it has been suggested that epigenetics could be involved. MicroRNAs (miRNAs), one of the epigenetic players, are small non-coding RNAs that can act as post-transcriptional regulators of gene expression, reducing the expression of their target mRNAs either inhibiting its translation or promoting its degradation. MiRNA expression profiles are specific of tissue and cell type. Abnormal miRNA expression has been described in different pathological conditions, such as a myriad of oncological, cardiovascular and inflammatory diseases and gynecological pathologies. In endometriosis, miRNA expression patterns of eutopic endometrium from patients and control women and from different endometriotic lesions have been described. These small non-coding molecules have become attractive candidates as novel biomarkers for an early non-invasive diagnosis of the disease, which could suppose a valuable benefit to the patients in terms of improvement of prognosis and reduction of the ratio of recurrence. In this systematic review we will focus on the role of miRNAs in the pathophisiology of endometriosis.

Keywords: MicroRNAs, Endometriosis, Epigenetics, Angiogenesis, Biomarkers

Core tip: Endometriosis is an estrogen-dependent inflammatory disorder that limits the quality of life of affected women. Nowadays, a unifying theory regarding its exact etiopathogenic mechanism has not been achieved yet. Our objective is to review the current literature to better understand the role of microRNAs, one of the epigenetic players, in the pathophisiology of endometriosis and their potential as novel diagnostic biomarkers to guide therapeutic interventions in endometriosis.